Bausch + Lomb Corporation Common Shares (NY:BLCO)

15.37 -0.52 (-3.27%)

Official Closing Price Updated: 4:10 PM EDT, Mar 27, 2026 Add to My Watchlist

Price and Volume

Volume	316,503
Open	15.74
Bid (Size)	15.00 (200)
Ask (Size)	17.00 (100)
Prev. Close	15.89
Today's Range	15.35 - 15.78
52wk Range	10.45 - 18.91
Shares Outstanding	353,800,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 Reasons BLCO is Risky and 1 Stock to Buy Instead

March 26, 2026

Even during a down period for the markets, Bausch + Lomb has gone against the grain, climbing to $16.01. Its shares have yielded a 10.4% return over the last...

Via StockStory

A Bausch + Lomb Director Just Bought $77,000 in Stock. That's Only Half the Story ↗

March 24, 2026

Bausch + Lomb, a global leader in eye health products and surgical devices, reported a recent insider buy amid ongoing sector activity.

Via The Motley Fool

Performance

YTD	-7.3%	-7.3%
1 Month	-16.6%	-16.6%
3 Month	-10.5%	-10.5%
6 Month	+7.0%	+7.0%
1 Year	-1.9%	-1.9%

More News

Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma

March 23, 2026

From Bausch + Lomb Corporation

Via Business Wire

Billboard Giant Posts $1.6 Billion Revenue as $20.5 Million Bet Makes It a Top Portfolio Holding ↗

March 12, 2026

Via The Motley Fool

Bausch + Lomb Corp (NYSE:BLCO) Reports Mixed Q4 2025 Results: Revenue Beat, EPS Miss ↗

February 18, 2026

Via Chartmill

Eye Care Giant Posts $5.1 Billion in Revenue as One Investor Builds Major Position ↗

March 12, 2026

Via The Motley Fool

Bausch + Lomb Launches R&D “Teach-in” Webinar Series

March 09, 2026

From Bausch + Lomb Corporation

Via Business Wire

Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know

March 06, 2026

Via StockStory

2 Profitable Stocks Worth Investigating and 1 We Ignore

March 04, 2026

Via StockStory

Viatris (VTRS): From Debt-Laden Merger to Specialty Powerhouse—A 2026 Research Deep Dive

March 03, 2026

Via Finterra

5 Revealing Analyst Questions From Bausch + Lomb’s Q4 Earnings Call

February 25, 2026

Via StockStory

Ophthalmology and Therapy Publishes Findings Showing Lifestyle-Driven Rise in Ocular Redness and Differentiated Role of LUMIFY®

February 24, 2026

From Bausch + Lomb Corporation

Via Business Wire

3 Small-Cap Stocks We Steer Clear Of

February 22, 2026

Via StockStory

BLCO Q4 2025 Deep Dive: Dry Eye and Product Innovation Propel Growth, Margin Expansion in Focus

February 19, 2026

Via StockStory

Bausch + Lomb’s (NYSE:BLCO) Q4 CY2025: Beats On Revenue

February 18, 2026

Via StockStory

Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance

February 18, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb (BLCO) Q4 Earnings: What To Expect

February 16, 2026

Via StockStory

3 Reasons to Sell BLCO and 1 Stock to Buy Instead

February 09, 2026

Via StockStory

1 Healthcare Stock to Research Further and 2 Facing Headwinds

January 29, 2026

Via StockStory

3 Stocks Under $50 That Fall Short

January 26, 2026

Via StockStory

3 Cash-Burning Stocks We’re Skeptical Of

January 22, 2026

Via StockStory

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2025 Financial Results on Feb. 18

January 20, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.

January 05, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Completes Refinancing of Outstanding Term B Loans

January 02, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference

December 23, 2025

From Bausch + Lomb Corporation

Via Business Wire

Frequently Asked Questions

Is Bausch + Lomb Corporation Common Shares publicly traded?

Yes, Bausch + Lomb Corporation Common Shares is publicly traded.

What exchange does Bausch + Lomb Corporation Common Shares trade on?

Bausch + Lomb Corporation Common Shares trades on the New York Stock Exchange

What is the ticker symbol for Bausch + Lomb Corporation Common Shares?

The ticker symbol for Bausch + Lomb Corporation Common Shares is BLCO on the New York Stock Exchange

What is the current price of Bausch + Lomb Corporation Common Shares?

The current price of Bausch + Lomb Corporation Common Shares is 15.37

When was Bausch + Lomb Corporation Common Shares last traded?

The last trade of Bausch + Lomb Corporation Common Shares was at 03/27/26 04:10 PM ET

What is the market capitalization of Bausch + Lomb Corporation Common Shares?

The market capitalization of Bausch + Lomb Corporation Common Shares is 5.44B

How many shares of Bausch + Lomb Corporation Common Shares are outstanding?

Bausch + Lomb Corporation Common Shares has 5B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.